- Grants since 2016
- 611
- Awarded, last 5 years (where amounts are published)
- €94.6M
- Funded works, last 5 years
- 5 837
- Funded works, all time
- 8 569
Grants
2020–2022 · grant
Dysregulated Frataxin processing in the pathogenesis of PITRM1-dependent spinocerebellar ataxia
Dario Brunetti · Fondazione Istituto Neurologico Carlo Besta - Irccs
2020–2022 · grant
Elucidating the Alsin structure to function relationships toward a better understanding of Infantile-onset ascending hereditary spastic paralysis and possible therapeutic strategies.
Marco Agostino Deriu · Politecnico di Torino
2019–2022 · grant
Flow Cytrometry Facility - FACS - CITOFLUORIMETRIA
Stefano Pepe · Telethon Institute Of Genetics And Medicine (tigem)
2019–2023 · grant
Towards Precision Medicine with Human Induced Pluripotent Stem Cells for Dystrophin Associated Cardiomyopathy.
Giulio Pompilio · Centro Cardiologico Monzino
2019–2024 · grant
Finding new targets to counteract brain progenitor cells dysregulation in AGC1 deficiency hypomyelination: a multi-disciplinary approach.
Barbara Monti · University of Bologna
2019–2021 · grant
Oxidative lipidomics in Barth Syndrome
Angela Corcelli · University of Bari Aldo Moro
2019–2023 · grant
Autosomal Dominant Osteopetrosis Type 2 (ADO2): close to the cure. What do we miss?
Anna Maria Teti · University of L'Aquila
2019–2023 · grant
Functional dissection of the molecular underpinnings of 7q11.23 syndromes: bridging pathogenic insight to drug discovery at single cell resolution
Giuseppe Testa · University of Milan
2019–2023 · grant
Plasmalogen-based therapeutic strategy for the treatment of Hereditary Spastic Paraplegia
Diana Pendin · National Research Council
2019–2022 · grant
Spermidine as new candidate for the treatment of COL6 myopathies (SpeCTre-COL6)
Paolo Bonaldo · University of Padua
2019–2022 · grant
A therapeutic approach for rare genodermatoses caused by aberrant connexin hemichannels
Fabio Mammano · National Research Council
2019–2023 · grant
Immune-mediated myocarditis in Fabry disease cardiomyopathy causes disease progression and resistance to enzyme replacement therapy. Influence of immunosuppressive therapy
Andrea Frustaci · Policlinico Umberto I
2019–2023 · grant
Interaction of PRRT2 with Na+ channels: pathogenetic basis and new targets for the cure of PRRT2- associated paroxysmal disorders
Fabio Benfenati · University of Genoa
2019–2023 · grant
Knockdown and Replacement of MFN2: a Gene Therapy to treat Dominantly Inherited Peripheral Neuropathy CMT2A
Stefania Corti · University of Milan
2019–2023 · grant
Toward gene therapy for Dravet syndrome: uncovering dynamics of reversibility and mechanisms of Scn1a gene modulation
Gaia Colasante · Fondazione Centro San Raffaele
2019–2023 · grant
Experimental gene therapy in mitochondrial disorders
Massimo Zeviani · Veneto Institute of Molecular Medicine
2019–2023 · grant
Intracellular chloride dynamics in autistic brain: a better understanding is needed for tailored cures.
Gian Michele Ratto · National Research Council
2019–2022 · grant
Molecular Mechanisms of Autophagy and Membranes Dynamics
Paolo Grumati · Telethon Institute Of Genetics And Medicine (tigem)
2019–2023 · grant
Alternative translation initiation as a novel strategy to block toxicity of the mutant Androgen Receptor in SBMA
Angelo Poletti · University of Milan
2019–2023 · grant
Exploiting whole-brain strategies of gene therapy and novel therapeutic targets in Rett syndrome mouse models
Vania Broccoli · Fondazione Centro San Raffaele
2019–2023 · grant
Genome-editing regulation of alternative splicing provides new therapeutic opportunities for episodic ataxia type II
Lorenzo Cingolani · University of Trieste
2019–2023 · grant
Optic atrophy 1 dependent signals in retinal ganglion cells: from identification to a therapy for autosomal dominant optic atrophy
Luca Scorrano · University of Padua
2019–2022 · grant
Hepatocyte-directed gene therapy for inherited disorders with liver fibrosis
Pasquale Piccolo · Telethon Institute Of Genetics And Medicine (tigem)
2019–2023 · grant
Gene editing in Myotonic Dystrophy type 1: assessment of efficiency, safety and therapeutic effect of CTG-repeat deletion in a mouse model of disease.
Germana Falcone · National Research Council
2019–2023 · grant
Pre-clinical identification of drugs targeting POLG disorders by using a Zebrafish/Yeast trans-species approach (ZIPPY)
Francesco Argenton · University of Padua
2019–2023 · grant
The role of SMN protein in translation: implications for Spinal Muscular Atrophy
Gabriella Viero · National Research Council
2019–2022 · grant
Hepatocyte-directed gene therapy for Wilson disease
Pasquale Piccolo · Telethon Institute Of Genetics And Medicine (tigem)
2019–2022 · grant
Study of disease pathogenesis and development of gene therapy for adenosine deaminase 2 deficiency
Alessandra Mortellaro · San Raffaele Telethon Institute For Gene Therapy - Sr-tiget
2019–2023 · grant
Mechanistic dissection of Polycomb-dependent dysregulation in Weaver syndrome neural lineages
Alejandro López Tobón · Fondazione Istituto Europeo Di Oncologia E Centro Cardiologico Monzino (fondazione Ieo-ccm)
2019–2023 · grant
Pigment Epithelium-derived Factor (PEDF) peptides as therapeutic agents for inherited retinal degeneration
Valeria Marigo · Università Degli Studi Di Modena E Reggio Emilia Unimore
2019–2023 · grant
Finding pharmacological treatments for Tubular Aggregate Myopathy
Armando Genazzani · Università degli Studi del Piemonte Orientale “Amedeo Avogadro”
2018–2021 · grant
Telethon Network of Genetic Biobanks
Luca Sangiorgi · Fondazione Telethon
2018–2021 · grant
A novel approach to the understanding and treatment of Hutchinson-Gilford Progeria Syndrome
Fabrizio D'Adda Di Fagagna · Ifom Ets - Istituto Fondazione Di Oncologia Molecolare
2018–2022 · grant
Development of Exon Specific U1 snRNA-based therapy for Familial Dysautonomia
Franco Pagani · International Centre for Genetic Engineering and Biotechnology
2018–2021 · grant
Solving the puzzle of protocadherin-19 mosaicism to understand the pathophysiology of PCDH19 Female Epilepsy (PCDH19-FE)
Silvia Bassani · National Research Council
2018–2022 · grant
Genetic and pharmacological rescue of TM4SF2 loss of function in animal model and iPS cells
Maria Passafaro · National Research Council
2018–2021 · grant
Fatal Familial Insomnia: preventive treatment with Doxycycline of at risk individuals
Gianluigi Forloni · Mario Negri Institute for Pharmacological Research
2018–2020 · grant
Unveiling the genetic predisposition to an increased autoimmunity risk in patients with glycogen storage disease type 1b
Giuseppe Matarese · University of Naples Federico II
2018–2021 · grant
Modulation of the cyclin inhibitor p27 to ameliorate Merosin Deficient Congenital Muscular Dystrophy (MDC1A)
Stefano Previtali · Fondazione Centro San Raffaele
2018–2021 · grant
Targeting neurons with cholesterol. How can it change the future of Huntington Disease patients
Elena Cattaneo · Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico